Tate & Lyle is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.
Through our expertise in sweetening, mouthfeel and fibre fortification, we develop solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.
We have more than 3,000 employees working in around 60 locations across 30 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on Twitter, LinkedIn or Facebook.
QHT focuses on digestive microbiota health. Its core products, fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS) , are widely recognized as essential prebiotics that have significant beneficial effects of a properly balanced human digestive microbiome.
QHT controls independent research and development core technologies and patented technologies.